Sleep disorders

Neurologic Clinics

Volumn 19, Issue 1, 2001, Pages 173-186

  Silber, Michael H ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BROMOCRIPTINE; CARBAMAZEPINE; CARBIDOPA PLUS LEVODOPA; CENTRAL STIMULANT AGENT; METHYLPHENIDATE; MODAFINIL; OPIATE AGONIST; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

CATAPLEXY; HYPNOSIS; NARCOLEPSY; PARASOMNIA; PRIORITY JOURNAL; REM SLEEP; RESTLESS LEGS SYNDROME; REVIEW; SLEEP DEPRIVATION; SLEEP DISORDER;

EID: 0035008155     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(05)70011-6     Document Type: Article

References (95)

1. Treatment of restless legs syndrome with gabapentin
2. Augmentation of the restless legs syndrome with carbidopa/levodopa
3. Periodic limb movements in sleep in community-dwelling elderly
4. Modafinil for narcolepsy
5. Carbamazepine in REM sleep behavior disorder
6. Idiopathic hypersomnia: A series of 42 patients
7. Narcolepsy
8. Dopaminergic agents in restless legs syndrome and periodic limb movements of sleep: Response and complications of extended treatment in 49 cases
9. Encouraging initial response of restless legs syndrome to pramipexole
10. Use of modafinil in the treatment of narcolepsy: A long term follow-up study
11. Health-related quality of life effects of modafinil for treatment of narcolepsy
12. Modafinil: A double-blind multicentric study
13. The treatment of the restless legs syndrome with clonazepam: A prospective controlled study
14. Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: A double-blind, controlled study
15. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy
16. A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms
17. Treatment of coexistent night-terrors and somnambulism in adults with imipramine and diazepam
18. Narcolepsy
19. A normative study of the maintenance of wakefulness test (MWT)
20. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients
21. Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome
22. Comparison of cognitive-behavioral therapy and clonazepam for treating periodic limb movement disorder
23. Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil
24. The use of scheduled awakenings to eliminate childhood sleepwalking
25. Non-pharmacological approaches to the treatment of narcolepsy
26. Change from conventional stimulants to modafinil in patients with narcolepsy or idiopathic hypersomnia
27. Diazepam (Valium) treatment in childhood sleep disorders: A preliminary investigation
28. Amphetamines and narcolepsy: Use of the Stanford database
29. Dopaminergic treatment of restless legs and rebound phenomenon
30. The alerting effects of short and long naps in narcoleptic, sleep deprived, and alert individuals
31. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review
32. Dyskinesias while awake and periodic movements in sleep in restless legs syndrome: Treatment with opioids
33. Successful long-term therapy of the restless legs syndrome with opioid medication
34. Long-term treatment of narcolepsy with methyphenidate (Ritalin)
35. A retrospective outcome study and review of hypnosis as treatment of adults with sleepwalking and sleep terror
36. A new method for measuring daytime sleepiness: The Epworth sleepiness scale
37. A new method for measuring daytime sleepiness: The Epworth sleepiness scale
38. A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene
39. Somnambulism in adults
40. Melatonin as a therapy in REM sleep behavior disorder patients: An open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation
41. Fluoxetine in the treatment of cataplexy
42. Polysomnographic features of REM sleep behavior disorder: Development of a scoring method
43. Novel and non-toxic treatment for night terrors
44. Treatment of restless legs syndrome with tramadol: An open study
45. Effect of pramipexole in treatment of resistant restless legs syndrome
46. Sleep practitioners need to be aware of new changes in the labeling of pemoline (CYLERT)
47. Restless legs, anxiety and caffeinism
48. Growth of hyperactive children on maintenance regimen of methylphenidate
49. Management of restless legs syndrome with gabapentin (Neurontin)
50. Are periodic limb movements associated with clinical sleep disturbances?
51. Narcolepsy and its treatment with stimulants: ASDA standards of practice
52. The treatment of excessive somnolence with stimulant drugs
53. Relative efficacy of drugs for the treatment of sleepiness in narcolepsy
54. Narcolepsy
55. Treatment of narcolepsy with methamphetamine
56. Long-term efficacy and safety of modafinil (Provigil) for the treatment of excessive daily sleepiness associated with narcolepsy
57. Clonazepam and vibration in restless legs syndrome
58. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteria
59. Serotoninergic reuptake mechanisms in the control of cataplexy
60. Restless legs syndrome improved by pramipexole: A double-blind randomized trial
61. Scheduled naps in the management of daytime sleepiness in narcolepsy-cataplexy
62. Is excessive daytime sleepiness with periodic leg movements during sleep a specific diagnostic category?
63. Pharmacological aspects of human and canine narcolepsy
64. Iron status and restless legs syndrome in the elderly
65. Restless legs syndrome in the elderly
66. Rapid eye movement sleep behavior disorder: Demographic, clinical and laboratory findings in 93 cases
67. Ropinirole for restless legs syndrome
68. Introduction to the mechanism of action of different treatments of narcolepsy
69. Natural history, symptoms and treatment of the narcoleptic syndrome
70. Treatment of payor nocturnus and somnambulism in children
71. Treatment of sleepwalking: A controlled study
72. Diazepam in intractable sleepwalking: A pilot study
73. Alerting effects of naps in narcolepsy
74. Compliance with stimulant medications in patients with narcolepsy
75. Chronic behavioral disorders of human REM sleep: A new category of parasomnia
76. REM sleep behaviour disorder: An update on a series of 96 patients and a review of the world literature
77. Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults
78. Motor dyscontrol in narcolepsy: Rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder
79. A polysomnographic, neurologic, psychiatric and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): Sustained clonazepam efficacy in 89.5% of 57 treated patients
80. Narcolepsy, paranoid psychosis, major depression, and tardive dyskinesia
81. The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: A double-blind study
82. Amphetamine, mazindol, and fencamfamin in narcolepsy
83. Restless legs syndrome
84. Pergolide in the management of restless legs syndrome: An extended study
85. Venlafaxine in the treatment of the narcoleptic syndrome
86. Practice parameters for the use of stimulants in the treatment of narcolepsy
87. Iron and the restless legs syndrome
88. Short-term triazolam use improves nocturnal sleep of narcoleptics
89. L-dopa therapy of uremic and idiopathic restless legs syndrome: A double-blind, crossover trial
90. Randomized trial of modafinil as a treatment for excessive daytime somnolence in narcolepsy
91. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy
92. Randomized, double-blind, placebo-controlled study of clonidine in restless legs syndrome
93. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome
94. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo
95. Treatment of narcolepsy with Ritalin